Quote:
Originally Posted by DaFace
What safety data are we looking for that they don't have? The trial was with ~44k people (maybe ~22k who got the vaccine assuming they split it in half), and they haven't seen any major safety issues yet.
I know they want a full 2 months of data (and I agree that it's needed before they actually start distributing things), but it's not like there's been a pile of safety issues that they just haven't looked at yet.
|
Maybe it is me but I think we would need more data than just a month. They also haven't said what age groups they have done but the speculation is they aren't doing children or the elderly yet for example.